The Clinical Relevance and Function of Krüppel-Like Factor 16 in Breast Cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
   PubMed Web of Science ®Google Scholar
• Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2):115–132. doi:10.3322/caac.2133826808342
   PubMed Web of Science ®Google Scholar
• Jung KW, Won YJ, Kong HJ, Lee ES. Prediction of cancer incidence and mortality in Korea, 2019. Cancer Res Treat. 2019;51(2):431–437. doi:10.4143/crt.2019.13930913864
   PubMed Web of Science ®Google Scholar
• Di Cosimo S, Baselga J. Management of breast cancer with targeted agents: importance of heterogeneity. [corrected]. Nat Rev Clin Oncol. 2010;7(3):139–147. doi:10.1038/nrclinonc.2009.23420125090
   PubMed Web of Science ®Google Scholar
• Bartlett JMS, Sgroi DC, Treuner K, et al. Breast Cancer Index and prediction of benefit from extended endocrine therapy in breast cancer patients treated in the Adjuvant Tamoxifen-To Offer More? (aTTom) trial. Ann Oncol. 2019;30(11):1776–1783. doi:10.1093/annonc/mdz28931504126
   PubMed Web of Science ®Google Scholar
• Braso-Maristany F, Griguolo G, Pascual T, et al. Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade. Nat Commun. 2020;11(1):385. doi:10.1038/s41467-019-14111-331959756
   PubMed Web of Science ®Google Scholar
• Gray E, Marti J, Wyatt JC, Brewster DH, Hall PS; group Sa. Chemotherapy effectiveness in trial-underrepresented groups with early breast cancer: a retrospective cohort study. PLoS Med. 2019;16(12):e1003006. doi:10.1371/journal.pmed.100300631891574
   PubMed Web of Science ®Google Scholar
• Bertucci F, Ng CKY, Patsouris A, et al. Genomic characterization of metastatic breast cancers. Nature. 2019;569(7757):560–564. doi:10.1038/s41586-019-1056-z31118521
   PubMed Web of Science ®Google Scholar
• Formisano L, Lu Y, Servetto A, et al. Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. Nat Commun. 2019;10(1):1373. doi:10.1038/s41467-019-09068-230914635
   PubMedGoogle Scholar
• McConnell BB, Yang VW. Mammalian Kruppel-like factors in health and diseases. Physiol Rev. 2010;90(4):1337–1381. doi:10.1152/physrev.00058.200920959618
   PubMed Web of Science ®Google Scholar
• Tetreault MP, Yang Y, Katz JP. Kruppel-like factors in cancer. Nat Rev Cancer. 2013;13(10):701–713. doi:10.1038/nrc358224060862
   PubMed Web of Science ®Google Scholar
• Hu CC, Liang YW, Hu JL, Liu LF, Liang JW, Wang R. LncRNA RUSC1-AS1 promotes the proliferation of breast cancer cells by epigenetic silence of KLF2 and CDKN1A. Eur Rev Med Pharmacol Sci. 2019;23(15):6602–6611. doi:10.26355/eurrev_201908_1854831378902
   PubMed Web of Science ®Google Scholar
• Lu F, Li C, Yu Y, et al. [KLF3 regulates the movement, migration and invasion of breast cancer cells through STAT3]. Zhonghua Yi Xue Za Zhi. 2019;99(38):3014–3018. Chinese. doi:10.3760/cma.j.issn.0376-2491.2019.38.01031607035
   PubMedGoogle Scholar
• Hu D, Zhou Z, Davidson NE, Huang Y, Wan Y. Novel insight into KLF4 proteolytic regulation in estrogen receptor signaling and breast carcinogenesis. J Biol Chem. 2012;287(17):13584–13597. doi:10.1074/jbc.M112.34356622389506
   PubMed Web of Science ®Google Scholar
• Chen CH, Yang N, Zhang Y, et al. Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers. Int J Biol Sci. 2019;15(8):1733–1742. doi:10.7150/ijbs.3513831360115
   PubMed Web of Science ®Google Scholar
• Guo P, Dong XY, Zhao KW, Sun X, Li Q, Dong JT. Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells. Int J Cancer. 2010;126(1):81–89. doi:10.1002/ijc.2469619569049
   PubMed Web of Science ®Google Scholar
• Liu J, Du T, Yuan Y, He Y, Tan Z, Liu Z. KLF6 inhibits estrogen receptor-mediated cell growth in breast cancer via a c-Src-mediated pathway. Mol Cell Biochem. 2010;335(1–2):29–35. doi:10.1007/s11010-009-0237-819707857
   PubMed Web of Science ®Google Scholar
• Hatami R, Sieuwerts AM, Izadmehr S, et al. An oncogenic splice variant drives EMT and metastasis in breastcancer. Cancer Discov. 2013;3(3):Of16. doi:10.1158/2159-8290.CDRW2013-027
   Google Scholar
• Wang X, Lu H, Urvalek AM, et al. KLF8 promotes human breast cancer cell invasion and metastasis by transcriptional activation of MMP9. Oncogene. 2011;30(16):1901–1911. doi:10.1038/onc.2010.56321151179
   PubMed Web of Science ®Google Scholar
• Lu H, Hu L, Yu L, et al. KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer. Oncogene. 2014;33(22):2909–2917. doi:10.1038/onc.2013.24723812425
   PubMed Web of Science ®Google Scholar
• Bai XY, Li S, Wang M, et al. Kruppel-like factor 9 down-regulates matrix metalloproteinase 9 transcription and suppresses human breast cancer invasion. Cancer Lett. 2018;412:224–235. doi:10.1016/j.canlet.2017.10.02729107105
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Li A, Gimotty PA, et al. KLF17 is a negative regulator of epithelial-mesenchymal transition and metastasis in breast cancer. Nat Cell Biol. 2009;11(11):1297–1304. doi:10.1038/ncb197419801974
   PubMed Web of Science ®Google Scholar
• Hsu CF, Sui CL, Wu WC, et al. Klf10 induces cell apoptosis through modulation of BI-1 expression and Ca2+ homeostasis in estrogen-responding adenocarcinoma cells. Int J Biochem Cell Biol. 2011;43(4):666–673. doi:10.1016/j.biocel.2011.01.01021262377
   PubMed Web of Science ®Google Scholar
• Jin W, Chen BB, Li JY, et al. TIEG1 inhibits breast cancer invasion and metastasis by inhibition of epidermal growth factor receptor (EGFR) transcription and the EGFR signaling pathway. Mol Cell Biol. 2012;32(1):50–63. doi:10.1128/MCB.06152-1122025675
   PubMed Web of Science ®Google Scholar
• Han M, Wang Y, Guo G, et al. microRNA-30d mediated breast cancer invasion, migration, and EMT by targeting KLF11 and activating STAT3 pathway. J Cell Biochem. 2018;119(10):8138–8145. doi:10.1002/jcb.2676729923255
   PubMed Web of Science ®Google Scholar
• Guan B, Li Q, Shen L, et al. MicroRNA-205 directly targets Krüppel-like factor 12 and is involved in invasion and apoptosis in basal-like breast carcinoma. Int J Oncol. 2016;49(2):720–734. doi:10.3892/ijo.2016.357327278159
   PubMed Web of Science ®Google Scholar
• Fan G, Sun L, Shan P, et al. Loss of KLF14 triggers centrosome amplification and tumorigenesis. Nat Commun. 2015;6:8450. doi:10.1038/ncomms945026439168
   PubMed Web of Science ®Google Scholar
• Yoda T, McNamara KM, Miki Y, et al. KLF15 in breast cancer: a novel tumor suppressor?. Cell Oncol. 2015;38(3):227–235.
   Web of Science ®Google Scholar
• Kim HS, Lee JU, Yoo TK, et al. Omission of chemotherapy for the treatment of mucinous breast cancer: a nationwide study from the Korean Breast Cancer Society. J Breast Cancer. 2019;22(4):599–612. doi:10.4048/jbc.2019.22.e4631897333
   PubMed Web of Science ®Google Scholar
• Yan Q, Zhang W, Wu Y, et al. KLF8 promotes tumorigenesis, invasion and metastasis of colorectal cancer cells by transcriptional activation of FHL2. Oncotarget. 2015;6(28):25402–25417. doi:10.18632/oncotarget.451726320172
   PubMedGoogle Scholar
• Suh Y, Noh SJ, Lee S, et al. Dopamine D1 receptor (D1R) expression is controlled by a transcriptional repressor complex containing DISC1. Mol Neurobiol. 2019;56(10):6725–6735.30915712
   PubMed Web of Science ®Google Scholar
• Jang MK, Lee S, Jung MH. RNA-Seq analysis reveals a negative role of KLF16 in adipogenesis. PLoS One. 2016;11(9):e0162238. doi:10.1371/journal.pone.016223827611969
   PubMed Web of Science ®Google Scholar
• Daftary GS, Lomberk GA, Buttar NS, et al. Detailed structural-functional analysis of the Kruppel-like factor 16 (KLF16) transcription factor reveals novel mechanisms for silencing Sp/KLF sites involved in metabolism and endocrinology. J Biol Chem. 2012;287(10):7010–7025. doi:10.1074/jbc.M111.26600722203677
   PubMed Web of Science ®Google Scholar
• Chen X, Li S, Ke Y, et al. KLF16 suppresses human glioma cell proliferation and tumourigenicity by targeting TFAM. Artif Cells Nanomed Biotechnol. 2018;46(sup1):608–615. doi:10.1080/21691401.2018.143165429374989
   PubMed Web of Science ®Google Scholar
• Ma P, Sun CQ, Wang YF, et al. KLF16 promotes proliferation in gastric cancer cells via regulating p21 and CDK4. Am J Transl Res. 2017;9(6):3027–3036.28670390
   PubMed Web of Science ®Google Scholar
• Xiong Y, Wang Z, Zhou Q, et al. Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients. J Immunother Cancer. 2020;8(1):e000447. doi:10.1136/jitc-2019-00044732217761
   PubMed Web of Science ®Google Scholar
• Weinberger P, Ponny SR, Xu H, et al. Cell cycle M-Phase genes are highly upregulated in anaplastic thyroid carcinoma. Thyroid. 2017;27(2):236–252. doi:10.1089/thy.2016.028527796151
   PubMed Web of Science ®Google Scholar
• Haffty BG, Yang Q, Reiss M, et al. Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. J Clin Oncol. 2006;24(36):5652–5657. doi:10.1200/JCO.2006.06.566417116942
   PubMed Web of Science ®Google Scholar
• Liedtke C, Mazouni C, Hess KR, et al. Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer. J Clin Oncol. 2008;26(8):1275–1281. doi:10.1200/JCO.2007.14.414718250347
   PubMed Web of Science ®Google Scholar
• Gonzalez DM, Medici D. Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal. 2014;7(344):re8. doi:10.1126/scisignal.200518925249658
   PubMed Web of Science ®Google Scholar
• Xia E, Bhandari A, Shen Y, Zhou X, Wang O. lncRNA LINC00673 induces proliferation, metastasis and epithelial-mesenchymal transition in thyroid carcinoma via Kruppel-like factor 2. Int J Oncol. 2018;53(5):1927–1938. doi:10.3892/ijo.2018.452430106140
   PubMed Web of Science ®Google Scholar
• Qin J, Zhou Z, Chen W, et al. BAP1 promotes breast cancer cell proliferation and metastasis by deubiquitinating KLF5. Nat Commun. 2015;6:8471. doi:10.1038/ncomms947126419610
   PubMed Web of Science ®Google Scholar